FOLH1 and pancreatic neoplasm: By immunohistochemical analysis, approximately 85% of colorectal cancer, 66% of gastric cancer and 84% of pancreatic cancer patients demonstrated expression of PSMA in capillaries within the tumor bed, which can be selectively targeted by [18F]DCFPyL [10,11].